Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells

Anti-Cancer Drugs

Volumn 11, Issue 8, 2000, Pages 665-672

  Bergamo, A ^a   Zorzet, S ^b   Gava, B ^a   Sorc, A ^a   Alessio, E ^b   Iengo, E ^b   Sava, G ^a,b  

^a Callerio Foundation   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Cytotoxicity; Ruthenium

Indexed keywords

DICHLOROTETRAKISDIMETHYLSULFOXIDE RUTHENIUM; IMIDAZOLE DERIVATIVE; IMIDAZOLIUMIMIDAZOLEDIMETHYLSULFOXIDETETRACHLORORUTHENATE; RUTHENIUM COMPLEX; SODIUM TETRAMETHYLENSULFOXIDEISOQUINOLINETETRACHLORORUTHENATE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MOUTH CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DIMETHYL SULFOXIDE; FLOW CYTOMETRY; HUMANS; MICE; ORGANOMETALLIC COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0033788178     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200009000-00012     Document Type: Article

References (23)

1. Sulfoxide ruthenium complexes: Non-toxic tools for the selective treatment of solid tumour metastases
2. New tumor-inhibiting metal complexes
3. Ruthenium complexes: Potential roles in anticancer pharmaceuticals
4. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
5. Chemical, biological and antitumor properties of ruthenium (II) complexes with dimethylsulfoxide
6. Antitumor activity of imidazolium bisimidazole tetrachlororuthanate(III)
7. Synthesis and characterisation of two new classes of ruthenium(III)-sulfoxide complexes with nitrogen donor ligand L
8. Cytostatic and antitumour properties of a new series of Pt(II) complexes with cyclopentylamine
9. Amino acid metabolism in mammalian cell cultures
10. TS/A: A new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma
11. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
12. Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro
13. New colorimetric cytotoxicity assay for anticancer-drug screening
14. Rapid simultaneous measurements of DNA, protein and cell volume in single cells from large mammalian cell populations
15. Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells
16. Effects of ruthenium complexes on experimental tumors: Irrelevance of cytotoxicity for metastasis inhibition
17. Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry
18. Down-regulation of tumor gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex
19. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
20. 4(DMSO)Im]. Selective inhibition of spontaneous lung metastases by the ruthenium complex
21. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin
22. Paracrine effects of IL-4 transfection on TS/A adenocarcinoma cells mediate reduced in vivo growth